| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/04/1994 | WO1994016726A1 Carcinoma associated antigen (ng1) monoclonal antibodies against ng1, methods of producing these antibodies and use therefor |
| 08/04/1994 | WO1994016722A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties |
| 08/04/1994 | WO1994016718A1 Genetic modification of neural stem cells |
| 08/04/1994 | WO1994016716A1 Recombinant virus immunotherapy |
| 08/04/1994 | WO1994016570A1 Production of human recombinant collagen in the milk of transgenic animals |
| 08/04/1994 | WO1994016550A1 Tomato spotted wilt virus |
| 08/04/1994 | WO1994013808A3 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 08/04/1994 | WO1994013785A3 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 08/04/1994 | CA2154882A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | CA2154695A1 Tomato spotted wilt virus |
| 08/04/1994 | CA2154171A1 Max-interacting proteins and related molecules and methods |
| 08/04/1994 | CA2153802A1 Chimeric selectins as simultaneous blocking agents for component selectin function |
| 08/04/1994 | CA2153790A1 Human monoclonal antibodies to cytomegalovirus |
| 08/04/1994 | CA2132871A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties |
| 08/04/1994 | CA2132637A1 Icam-related protein |
| 08/03/1994 | EP0608696A2 Heterologous signal sequences for secretion of insect controlling proteins |
| 08/03/1994 | EP0608546A2 Glia activating factor (GAF), antibodies against it and their uses |
| 08/03/1994 | EP0608334A1 Sperm surface protein |
| 08/03/1994 | EP0608261A1 Immunoreactive hepatitis c virus polypeptide compositions |
| 08/03/1994 | EP0608260A1 Peptide inhibitors of inflammation mediated by selectins |
| 08/03/1994 | EP0255537B1 Assays for myasthenia gravis and substrates and kits for use therein |
| 08/03/1994 | EP0220234B1 EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV |
| 08/03/1994 | CN1090326A Mammalian receptors for interleukin-10 (IL-10) |
| 08/03/1994 | CN1090203A Polypeptide vaccine for aftosa and its preparation |
| 08/03/1994 | CN1090201A Angiotensin converting enzyme inhibitor and method for preparing same |
| 08/03/1994 | CN1025549C Production of water soluble and complete component pear powder |
| 08/02/1994 | US5334531 Plasmid vector for expression in bacillus and used for cloning the structural gene which codes for the human growth hormone and a method of producing the hormone |
| 08/02/1994 | US5334512 Genetic engineering |
| 08/02/1994 | US5334511 Microorganism escherichia contains recombiant DNA, culturing |
| 08/02/1994 | CA2113669A1 Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone h1, and uses therefor |
| 08/02/1994 | CA1331157C Method for producing factor viii:c-type proteins |
| 08/02/1994 | CA1331155C Baculovirus transfer vectors |
| 08/02/1994 | CA1331134C Purification of pertussis toxins |
| 07/27/1994 | EP0608117A2 Antibodies for mevalonic acid and methods for determination of mevalonic acid |
| 07/27/1994 | EP0608004A2 Human DNA in the diagnosis of retinoblastoma |
| 07/27/1994 | EP0607593A2 Process for obtaining cell cultures with a higher content of autologous cytonines |
| 07/27/1994 | EP0607425A1 Epstein-barr virus peptides and antibodies against these peptides |
| 07/27/1994 | EP0607332A1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 07/27/1994 | EP0607309A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 07/27/1994 | EP0607297A1 Hormone analogs with multiple ctp extensions |
| 07/27/1994 | EP0607247A1 Production of gpa neurotrophic factor |
| 07/27/1994 | EP0607178A1 Methods for the selection, separation and fusion of cells |
| 07/27/1994 | EP0491713B1 Rubella e1 and c peptides |
| 07/27/1994 | EP0346500B1 Elastase inhibiting polypeptides and process for their preparation by genetic recombination |
| 07/27/1994 | CN1089951A Novel glycoforms of soluble complement receptor 1 |
| 07/26/1994 | US5332804 High molecular weight human angiogenic basic fibroblast growth factors |
| 07/26/1994 | US5332671 Production of vascular endothelial cell growth factor and DNA encoding same |
| 07/26/1994 | US5332658 Recombinant human rotavirus VP7 serotype 4 |
| 07/26/1994 | US5332567 Detection and treatment of infections with immunoconjugates |
| 07/26/1994 | US5332551 Atomic oxygen reactor having at least one sidearm conduit |
| 07/26/1994 | CA2113981A1 Codon optimized dna sequence for insect toxin aait |
| 07/26/1994 | CA2113979A1 Heterologous signal sequences for secretion of insect controlling proteins |
| 07/26/1994 | CA1330961C Auto-anti-idiotypic monoclonal antibodies to steroid receptors and uses thereof |
| 07/21/1994 | WO1994016332A1 Method for screening catalytic non-enzyme polypeptides and proteins |
| 07/21/1994 | WO1994016314A1 Method of using preserved control cells in the calibration of fluorescent and light scatter measurements |
| 07/21/1994 | WO1994016094A2 Recombinant anti-vla4 antibody molecules |
| 07/21/1994 | WO1994016093A1 Antibodies specific for ehv-1 and the use of such antibodies in the detection of ehv-1 |
| 07/21/1994 | WO1994016091A1 A process for producing immunosuppressives and a novel microbial species to be employed therein |
| 07/21/1994 | WO1994016089A1 Viral amplification of recombinant messenger rna in transgenic plants |
| 07/21/1994 | WO1994016081A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 07/21/1994 | WO1994016074A2 High molecular weight b-cell growth factor: interleukin-14 |
| 07/21/1994 | WO1994016070A1 Leukocyte derived growth factors |
| 07/21/1994 | WO1994016069A2 Ras associated gap proteins |
| 07/21/1994 | WO1994016068A2 Allergenic proteins and peptides from dog dander and uses therefor |
| 07/21/1994 | WO1994016067A1 Serotoninergic receptors (5ht6 and 5ht7) and use thereof |
| 07/21/1994 | WO1994016066A1 Agents for the prevention and treatment of hiv replication and aids in humans |
| 07/21/1994 | WO1994016059A1 Method for production of neuroblasts |
| 07/21/1994 | WO1994015969A1 Recombinant anti-hiv antibody and preparation thereof |
| 07/21/1994 | WO1994015966A1 Growth differentiation factor-9 |
| 07/21/1994 | WO1994015965A1 Growth differentiation factor-3 |
| 07/21/1994 | WO1994015950A1 Purification of immunoglobulin |
| 07/21/1994 | WO1994015949A1 Growth differentiation factor-5 |
| 07/21/1994 | WO1994015942A1 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene |
| 07/21/1994 | WO1994015646A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 07/21/1994 | WO1994015644A1 Compounds for targeting |
| 07/21/1994 | WO1994015641A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | WO1994015638A1 Antibodies directed against binding-associated epitopes |
| 07/21/1994 | WO1994015637A2 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptides |
| 07/21/1994 | WO1994015627A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | WO1994015593A1 Novel parasitic helminth proteins |
| 07/21/1994 | WO1994012648A3 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
| 07/21/1994 | WO1994012639A3 Interleukin-3 (il-3) mutant polypeptides |
| 07/21/1994 | DE4400659A1 Prodn. of viral membrane protein domains |
| 07/21/1994 | CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | CA2153654A1 Growth differentiation factor-5 |
| 07/21/1994 | CA2153652A1 Growth differentiation factor-3 |
| 07/21/1994 | CA2153486A1 Ras associated gap proteins |
| 07/21/1994 | CA2153409A1 Leukocyte derived growth factors |
| 07/21/1994 | CA2153344A1 Method of using preserved control cells in the calibration of fluorescent and light scatter measurements |
| 07/21/1994 | CA2153241A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | CA2153158A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 07/21/1994 | CA2153065A1 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene |
| 07/21/1994 | CA2152934A1 Viral amplification of recombinant messenger rna in transgenic plants |
| 07/21/1994 | CA2152915A1 Antibodies directed against binding-associated epitopes |
| 07/21/1994 | CA2152818A1 Allergenic proteins and peptides from dog dander and uses therefor |
| 07/21/1994 | CA2152597A1 Method for production of neuroblasts |
| 07/21/1994 | CA2131623A1 Prevention of suppression of immune defence against cancer caused by the cancer-associated scm-recognition peptides |
| 07/21/1994 | CA2113866A1 Antibodies for mevalonic acid and methods for determination of mevalonic acid |
| 07/20/1994 | EP0607054A2 Novel process for constructing a cDNA library and a novel polypeptide and DNA coding the same |
| 07/20/1994 | EP0606921A1 Method of isolating haemophilus influenzae protein E |